SPIRIT OF MUMBAI

 Artist Viveek Sharma presents Sacred Gestures, honoring feminine strength and grace through richly detailed canvases If you’re exploring Mumbai’s cultural circuit this weekend, make space for Viveek Sharma’s SACRED GESTURES—a compelling exhibition that transforms traditional and contemporary ideas of femininity into immersive visual experiences. Known for his dramatic light, saturated pigments and meticulous detailing, Sharma bridges the real and the imagined through canvases inspired by Lavani traditions, divine feminine archetypes and iconic figures from popular culture. The exhibition is to be inaugurated on 2nd December at 6:30 PM by Shobhaa De (author, columnist, novelist) and Rashmin Majithia (Founder, Zen Crafart), setting the tone for a showcase that celebrates strength, grace, passion and transformation. Thought-provoking and visually rich, it stands out as one of the week’s most compelling art events. Dates: 3–8 December, 11 AM–7 PM Venue: Jehangir Art Gallery, Kala Ghod...

  Collaboration to facilitate advanced biologics testing by providing HCP coverage, characterization and quantification assays, and related services to customers globally New center will help improve safety, efficacy, and quality in biopharma development Combination of Cytiva's analytical technologies with Veeda's extensive service delivery capabilities and regulatory expertise     November 28, 2025:  Cytiva, a Danaher company and a leader in the life sciences industry, is collaborating with Veeda Lifesciences (Veeda Clinical Research Limited), a global contract research organization, to establish a dedicated Host Cell Protein (HCP) Services Center in Bengaluru, India. Focused on impurity analysis and HCP testing, this new center will help biopharmaceutical companies reduce development risks and meet regulatory standards for novel biologics and biosimilars.   Dr. Mahesh Bhalgat, Group CEO and Managing Director, Veeda Lifesciences (Veeda Clinical Research Limited...

Mumbai, November 26, 2025:   Utkarsh Small Finance Bank Limited (Utkarsh SFBL) today announced a strategic partnership with Axis Securities to provide end-to-end trading and investment services for its customers.  This collaboration marks a significant step in expanding the Bank’s capabilities to deliver next-generation financial solutions.   This partnership introduces a unique 3-in-1 account, seamlessly integrating a Savings Account with Utkarsh Small Finance Bank and a Demat and Trading Account with Axis Securities.  This offering is designed to provide customers with a convenient and comprehensive platform for banking and investing.   Aligned with Utkarsh Small Finance Bank’s strategy to offer a full spectrum of financial services—including savings and current accounts, deposits, loans, insurance, and investment products—the partnership with Axis Securities will enable customers to seamlessly integrate banking and investing through multiple channels such as ...

  Penang, Malaysia —   The World Miniature Hobby Show (WMHS) & Malaysia Competition (MALCOM) is set to take place from 13th to 14th June 2026 at the Setia SPICE Convention Centre, promising to be the most anticipated gathering of miniature artists, hobbyists, and enthusiasts from around the world. Building upon a decade of growth and evolution, this homegrown event—previously known as the Malaysia International Miniatures and Hobby Show—has rebranded to reflect its growing global stature and influence within the creative hobby industry.

The Initial Public Offering of Sudeep Pharma was subscribed a massive 93.71 times on the final day of bidding. The issue received bids of 99,00,86,575 shares against the offered 1,05,64,926 equity shares, at a price band of ₹563-593, according to the data available on the stock exchanges. Qualified Institutional Buyer Portion and Non-Institutional Investors Portion were subscribed 213.1 times and 116.7 times respectively, whereas Retail Portion was subscribed 15.65 times.  The issue kicked off for subscription on Friday, November 21, 2025 and closed for subscription on Tuesday, November 25, 2025. ICICI Securities and IIFL Capital Services Ltd  are the book-running lead manager; and MUFG Intime India Private Limited is the registrar of the offer. Company Information The company is a technology-led manufacturer of excipients and specialty ingredients for the pharmaceutical, food and nutrition industries and is dedicated to contributing to the global heal...

Mumbai, November 25:  Sahajanand Medical Technologies has received final approval from the capital markets regulator, Securities and Exchange Board of India (SEBI), for its initial public offering (IPO). The Company had filed its IPO papers with Sebi on July 25, 2025. The IPO consists of an offer-for-sale of shares of up to 27,644,231 Equity Shares of face value of ₹1 each by promoters - Shree Hari Trust, Dhirajkumar Savjibhai Vasoya and Samara Capital Markets Holding Limited. Other investors selling shares are Kotak Pre-IPO Opportunities Fund and NHPEA Sparkle Holding B V. Incorporated in 2001, the company is a Class III and Class C/D medical devices company with a portfolio of technologically advanced medical devices across vascular and structural heart intervention. According to F&S Report, the company was the first player globally to receive a CE certification for a DES with a biodegradable polymer (Infinnium). Over the years, the company has introduced innovative products,...

·         India’s first ever index fund designed to track the Nifty MidSmallcap 400 Index – a diversified benchmark combining the Nifty Midcap150 and Nifty Smallcap 250 indices. ·         NFO opens on 24th November and closes on 05th December ·         Investment amount starts from INR 100. India, 25 November 2025:  Navi AMC, a subsidiary of Navi Limited ( formerly Navi Technologies Limited ), announced the launch of the Navi Nifty MidSmallcap 400 Index Fund, an open-ended index fund that seeks to replicate and track the Nifty MidSmallcap 400 Index. The index represents the combined universe of mid-cap and small-cap companies as defined within the broader Nifty 500. The New Fund Offer (NFO) opens on 24th November 2025 and closes on 5th December 2025. Fund & Index Overview The Scheme will replicate the Nifty MidSmallcap 400 Total Return Index, a free-float market capitalizati...

The Initial Public Offering of Sudeep Pharma Limited was subscribed 5.09 times on the second day of bidding, demonstrating strong demand from retail and non-institutional investors for this IPO. The issue received bids of 5,38,15,050 against the offered 1,05,64,926 equity shares, according to data available on the stock exchanges. Retail Portion and Non-institutional portion were subscribed 4.97 and 12 times respectively. Qualified Institutional Investors was subscribed 0.13 times. The issue kicked off for subscription on Friday, November 21, 2025 and will close for subscription on Tuesday, November 25, 2025. A day before the opening of the issue, Sudeep Pharma Limited had raised Rs 268.5 crore from anchor investors. Leading investors like Mukul Agarwal of Param Capital (Sanshi Fund-I), Prashant Khemka of Whiteoak, Akash Bhansali of ENAM and Prashant Jain from 3P Investment were also a part of the Anchor book.   Leading brokerage firms like Marwadi Financial Services and SBICa...